CTGi vs NeoCardioLab
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CTGi
This app simulates a fetal heart rate monitor for obstetric training. It offers a realistic and economical platform for facilitators and students to learn and practice. Utilizing everyday technology, it provides an advanced simulation experience.
- Realistic fetal heart rate monitoring simulation
- Economical training solution
- Ideal for in-situ training
- Advanced obstetric simulation
- Built with everyday technology
Read full descriptionHide full description
CTGi provides an economical, highly advanced and realistic fetal heart rate monitor simulation package. Using just two iPads, the lightness and simplicity of CTGi makes it ideal for in-situ training. CTGi gives facilitators a great tool for training and students an incredibly realistic platform to learn from. CTGi offers obstetric simulation as you’ve never seen it before, built off technology you use every day.
NeoCardioLab
This app offers extensive educational content on neonatal hemodynamics and cardiovascular research. It provides learning modules, video clips, and an atlas for understanding echocardiography, POCUS, and congenital heart defects.
- Neonatal hemodynamics education
- Echocardiography (2D & 3D) modules
- Targeted Neonatal Echocardiography (TnECHO)
- Point of Care Ultrasound (POCUS) training
- Near Infrared Spectroscopy (NIRS) modules
- Congenital heart defect resources
- Research updates and webinars
Read full descriptionHide full description
The NeoCardioLab is a research laboratory interested in clinical and epidemiological neonatal cardiovascular research, as well as education in neonatal hemodynamics. The principal investigator of the NeoCardioLab is Dr. Gabriel Altit from the Montreal Children’s Hospital (at McGill University). On the NeoCardioLab website, we have made available for the learners a whole array of content (clips, videos, presentations, reading material, articles, etc.) as a learning opportunity on echocardiography (2D and 3D), TnECHO (targeted neonatal echocardiography), point of care ultrasound (POCUS) and near infrared spectroscopy (NIRS). You will find on the website, our comprehensive “Atlas” for the expected normal complete neonatal echocardiography (with clips of various views and explanations), as well as clips for selected congenital heart defects. Our training modules are: on NIRS in the neonatal intensive care unit, as well as on POCUS/TnECHO. We offer modules on TnECHO (Targeted Neonatal Echocardiography; with clips outlining all the views and measurements, pulmonary hypertension, PDA, normative values, etc.), POCUS (as well as the example of the use of a hand-held device and how to obtain views) and Congenital Heart defects, as well as modules on Strain/Speckle Tracking and Near Infrared Spectroscopy. We also now host the Neonatal NIRS consortium page and all the recordings of their webinars. Please feel free to navigate the app and use it for training purposes and as a resource to complement your other learning materials. We are constantly updating the website and adding new content. You will also find information on the McGill University Neonatal Hemodynamics Clinical Research training program, if you are interested. Our research uses conventional and advanced echocardiography (speckle-tracking echocardiography on 2D and 3D acquisitions) to better understand the cardiovascular adaptation of newborns with various conditions (such as: prematurity, bronchopulmonary dysplasia, congenital heart defect, congenital diaphragmatic hernia, omphalocele and hypoxic ischemic encephalopathy). We also study cohorts of patients once they have graduated the neonatal intensive care unit (in neonatal follow-up, in the pediatric clinics, as well as during adulthood). Please feel free to contact us if you have questions or suggestions: info@neocardiolab.com. We also have Twitter (@CardioNeo) and Instagram (@NeoCardioLab).
Screenshots
Verdict
The clearest difference is update cadence: NeoCardioLab at weekly against CTGi's every 3 months. NeoCardioLab also leads on device support (3 vs 1). On price, rating, ratings volume and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for CTGi against 5.0 for NeoCardioLab. Both are backed by a comparable volume of ratings — 2 and 5 respectively.
CTGi ships an update every 3 months, NeoCardioLab weekly. The most recent releases landed on September 1, 2026 and June 5, 2026 respectively.
| Parameter | CTGi | NeoCardioLab |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) | 5.0 (5 ratings) |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | 2 | 5 — better |
| Update frequency | Every 3 months | Weekly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPad | iPhone, iPad, iPod — better |
| Requires iOS | 13.0 | 13.0 |
| Further details — not scored | ||
| Size | 23 MB | 35 MB |
| Age rating | 17+ | 17+ |
| Developer | iSimulate Pty Ltd | gabriel altit |
Customer experience
CTGi
NeoCardioLab
In-app purchases
CTGi
No in-app purchases
NeoCardioLab
No in-app purchases






